Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

IL-4 receptor engagement in human neutrophils impairs their migration and extracellular trap formation.

Impellizzieri D, Ridder F, Raeber ME, Egholm C, Woytschak J, Kolios AGA, Legler DF, Boyman O.

J Allergy Clin Immunol. 2019 Feb 12. pii: S0091-6749(19)30203-9. doi: 10.1016/j.jaci.2019.01.042. [Epub ahead of print]

PMID:
30768990
2.

Group A Streptococcal DNase Sda1 Impairs Plasmacytoid Dendritic Cells' Type 1 Interferon Response.

Keller N, Woytschak J, Heeb LEM, Marques Maggio E, Mairpady Shambat S, Snäll J, Hyldegaard O, Boyman O, Norrby-Teglund A, Zinkernagel AS.

J Invest Dermatol. 2019 Jun;139(6):1284-1293. doi: 10.1016/j.jid.2018.11.027. Epub 2018 Dec 10.

PMID:
30543898
3.

Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2.

Arenas-Ramirez N, Zou C, Popp S, Zingg D, Brannetti B, Wirth E, Calzascia T, Kovarik J, Sommer L, Zenke G, Woytschak J, Regnier CH, Katopodis A, Boyman O.

Sci Transl Med. 2016 Nov 30;8(367):367ra166.

PMID:
27903862
4.

Type 2 Interleukin-4 Receptor Signaling in Neutrophils Antagonizes Their Expansion and Migration during Infection and Inflammation.

Woytschak J, Keller N, Krieg C, Impellizzieri D, Thompson RW, Wynn TA, Zinkernagel AS, Boyman O.

Immunity. 2016 Jul 19;45(1):172-84. doi: 10.1016/j.immuni.2016.06.025.

5.

Interleukin-2: Biology, Design and Application.

Arenas-Ramirez N, Woytschak J, Boyman O.

Trends Immunol. 2015 Dec;36(12):763-777. doi: 10.1016/j.it.2015.10.003. Epub 2015 Nov 10. Review.

6.

Limitations of IL-2 and rapamycin in immunotherapy of type 1 diabetes.

Baeyens A, Pérol L, Fourcade G, Cagnard N, Carpentier W, Woytschak J, Boyman O, Hartemann A, Piaggio E.

Diabetes. 2013 Sep;62(9):3120-31. doi: 10.2337/db13-0214. Epub 2013 May 13.

7.

Cloning and characterization of novel tumor-targeting immunocytokines based on murine IL7.

Pasche N, Woytschak J, Wulhfard S, Villa A, Frey K, Neri D.

J Biotechnol. 2011 Jun 10;154(1):84-92. doi: 10.1016/j.jbiotec.2011.04.003. Epub 2011 Apr 16.

PMID:
21527292
8.

Genomics drugs in clinical trials.

Hall J, Dennler P, Haller S, Pratsinis A, Säuberli K, Towbin H, Walther K, Woytschak J.

Nat Rev Drug Discov. 2010 Dec;9(12):988. doi: 10.1038/nrd1552-c1. No abstract available. Erratum in: Nat Rev Drug Discov. 2011 Feb;10(2):156. Walthe, Katja [corrected to Walther, Katja].

PMID:
21119735

Supplemental Content

Loading ...
Support Center